Phathom Pharmaceuticals, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
PHAT on Nasdaq
Industry
Pharmaceutical Preparations
Location
100 Campus Drive,, Suite 102, Florham Park, NJ

Insiders trading volume in the past year

Phathom Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Medicxi Ventures Management (Jersey) Ltd 10%+ Owner $60.5M Jan 24, 2024
Takeda Pharmaceutical Co Ltd 10%+ Owner $30.4M Jan 24, 2024
James N. Topper Director, 10%+ Owner $19.6M +$192K +0.99% Jun 3, 2025
David A. Socks Director $11.2M May 23, 2024
Azmi Nabulsi Chief Operating Officer $10M -$60.9K -0.6% Feb 27, 2025
Terrie Curran President and Chief Executive, Director $2.4M -$126K -4.98% Feb 27, 2025
Molly Henderson CFO and CBO $1.56M -$70.4K -4.32% Apr 7, 2025
Robert Charles Breedlove Principal Accounting Officer $666K -$5.57K -0.83% Sep 5, 2025
Steven L. Basta President and CEO, Director $485K Sep 25, 2025
Asit Parikh Director $376K +$150K +66.8% Jun 3, 2025
Frank Karbe Director $223K +$99.1K +79.7% Jun 3, 2025
Michael F. Cola Director $132K Jun 3, 2025
Heidi Fields Director $99.3K Jun 3, 2025
Mark Stenhouse Director $99.3K Jun 3, 2025
Theodore R. Schroeder Director $95.6K Apr 16, 2025
Anthony J. Guzzo VP, Chief Accounting Officer $71.8K Jan 19, 2022
Anne Marie Cook Chief Legal Off. & Corp. Sec. Jun 23, 2025
Tadataka Yamada Director May 21, 2021

Recent Insider Transactions by Companies or Individuals for Phathom Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.